| 000 | 01350 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513195849.0 | ||
| 264 | 0 | _c19991216 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1177/00912709922012006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, D K | |
| 245 | 0 | 0 |
_aThe contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cDec 1999 |
||
| 300 |
_a1203-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aAryl Hydrocarbon Hydroxylases |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xmetabolism |
| 650 | 0 | 4 | _aPharmacokinetics |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 39 _gno. 12 _gp. 1203-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/00912709922012006 _zAvailable from publisher's website |
| 999 |
_c10542556 _d10542556 |
||